Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Hartford Multifactor Developed Markets (ex-US) ETF	RODM	17. avr 2025	31.12	+0.91
Harvard Bioscience	HBIO	17. avr 2025	0.39	-0.51
Hasbro	HAS	17. avr 2025	52.65	+1.48
Hauchen AI Parking Management Technology	HCAI	17. avr 2025	7.84	0.00
Haverty Furniture Companies	HVT	17. avr 2025	17.71	+3.03
Haverty Furniture Companies	HVT-A	17. avr 2025	17.28	0.00
Hawaiian Electric Industries	HE	17. avr 2025	10.45	+0.97
Hawkins	HWKN	17. avr 2025	121.63	+0.34
Hawthorn Bancshares	HWBK	17. avr 2025	29.20	+1.53
Haymaker Acquisition 4	HYAC	17. avr 2025	10.96	-0.27
Hayward	HAYW	17. avr 2025	12.00	+0.93
HBT Financial	HBT	17. avr 2025	21.99	+0.07
HCA Healthcare	HCA	17. avr 2025	335.01	+1.21
HCI Group	HCI	17. avr 2025	146.09	+0.16
HCM II Acquisition	HOND	17. avr 2025	10.72	+0.05
HCM II Acquisition	HONDU	17. avr 2025	11.07	0.00
HCW Biologics	HCWB	17. avr 2025	7.05	-7.60
HDFC Bank ADR	HDB	17. avr 2025	72.04	+4.01
Health Catalyst	HCAT	17. avr 2025	3.84	+2.40
Health In Tech	HIT	17. avr 2025	0.69	+2.82
Healthcare Alphadex First Trust	FXH	17. avr 2025	96.22	-0.13
Healthcare Bull 3X Direxion	CURE	17. avr 2025	82.94	-2.01
Healthcare ETF Vanguard	VHT	17. avr 2025	246.13	-0.42
Healthcare Realty Trust	HR	17. avr 2025	16.00	+1.91
Healthcare Select Sector SPDR	XLV	17. avr 2025	135.49	-0.59
Healthcare Services Group	HCSG	17. avr 2025	9.52	-0.31
Healthcare Triangle	HCTI	17. avr 2025	0.20	+1.85
HealthEquity	HQY	17. avr 2025	84.52	+2.46
Healthpeak Properties	DOC	17. avr 2025	18.75	+0.92
HealthStream	HSTM	17. avr 2025	32.39	-0.25

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.